Correction to: International Journal of Hematology 10.1007/s12185-022-03349-1
In the original publication of the article, the table related to case study was missing. The case study table is given in this correction.
| Case | Disease | CD20 MoAb*1 | SARS-CoV2 | Anti-SARS-CoV-2 Antibodies (AU/mL)*2 | Serum IgG (mg/dL)*3 | Time*4 | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Infection | Vaccine | IgG-N | IgM-N | IgG-S1 | IgM-S1 | Nab | |||||
| Case 1 | FL | 37 | + | − | n.t.*5 | n.t | n.t | n.t | 0.68 | 563 | + 2w |
| 0.27 | 0.14 | 0.39 | 0.21 | 3.48 | 441 | + 4w | |||||
| 0.19 | 0.33 | 0.37 | 0.23 | 1.44 | 183 | + 10w | |||||
| Case 2 | FL | 1 | + | − | 9.46 | 0.82 | 0.47 | 0.48 | 2.37 | 685 | + 2w |
| 235.22 | 29.82 | 16.79 | 2.23 | 21.21 | 576 | + 4w | |||||
| Case 3 | FL | 12 | + | + | 0.32 | 1.12 | 7.09 | 594.44 | 140.16 | 492 | + 2w |
| 0.32 | 0.95 | 8.01 | 578.75 | 213.00 | 461 | + 4w | |||||
| Case 4 | Healthy | 0 | − | + | 0.53 | 0.16 | 9.78 | 0.63 | 5.88 | 1,290 | + 2w |
| 0.50 | 0.17 | 2145.96 | 18.97 | 2836.82 | 1,291 | + 4w | |||||
*1: Number of anti-CD20 monoclonal antibody-containing chemotherapy sessions administered in each case
*2: Bold numbers with underline mean positive antibody titers (> 10 AU/mL)
*3: Reference interval of serum IgG is 861–1747 mg/dL in our hospital
*4: In Cases 1–3, time from the onset of SARS-CoV2 infection. In Case 4, time from the initial vaccination
*5: n.t.: not tested
Footnotes
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.